Literature DB >> 16882973

TXR1-mediated thrombospondin repression: a novel mechanism of resistance to taxanes?

Renée van Amerongen1, Anton Berns.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16882973     DOI： 10.1101/gad.1460806

Source DB:  PubMed          Journal:  Genes Dev        ISSN： 0890-9369            Impact factor:   11.361


× No keyword cloud information.
  10 in total

1.  Circadian variations in rat liver gene expression: relationships to drug actions.

Authors:  Richard R Almon; Eric Yang; William Lai; Ioannis P Androulakis; Debra C DuBois; William J Jusko
Journal:  J Pharmacol Exp Ther       Date:  2008-06-18       Impact factor: 4.030

2.  Molecular characterization of PRR13 and its tissue-specific expression in rainbow trout (Oncorhynchus mykiss).

Authors:  Marieke Verleih; Alexander Rebl; Bernd Köllner; Tomáš Korytář; Günter Kotterba; Eckhard Anders; Klaus Wimmers; Tom Goldammer
Journal:  Fish Physiol Biochem       Date:  2010-06-05       Impact factor: 2.794

Review 3.  Evolving standards in the treatment of docetaxel-refractory castration-resistant prostate cancer.

Authors:  E S Antonarakis; A J Armstrong
Journal:  Prostate Cancer Prostatic Dis       Date:  2011-05-17       Impact factor: 5.554

4.  Sensitization of breast cancer cells to taxol by inhibition of taxol resistance gene 1.

Authors:  Zhigang Bai; Zhongtao Zhang; Xiang Qu; Wei Han; Xuemei Ma
Journal:  Oncol Lett       Date:  2011-09-09       Impact factor: 2.967

5.  Extracellular matrix proteins modulate antimigratory and apoptotic effects of Doxorubicin.

Authors:  Georges Said; Marie Guilbert; Hamid Morjani; Roselyne Garnotel; Pierre Jeannesson; Hassan El Btaouri
Journal:  Chemother Res Pract       Date:  2012-07-01

Review 6.  Role of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate Cancer.

Authors:  Vipin Lohiya; Jeanny B Aragon-Ching; Guru Sonpavde
Journal:  Clin Med Insights Oncol       Date:  2016-10-09

7.  Effects of taxol resistance gene 1 on the cisplatin response in gastric cancer.

Authors:  Shuquan Duan; Jie Yin; Zhigang Bai; Zhongtao Zhang
Journal:  Oncol Lett       Date:  2018-03-30       Impact factor: 2.967

8.  Crizotinib, a MET inhibitor, inhibits growth, migration, and invasion of breast cancer cells in vitro and synergizes with chemotherapeutic agents.

Authors:  Nehad M Ayoub; Kamal M Al-Shami; Mohammad A Alqudah; Nizar M Mhaidat
Journal:  Onco Targets Ther       Date:  2017-10-05       Impact factor: 4.147

9.  Thrombospondin-1 Receptor CD47 Overexpression Contributes to P-Glycoprotein-Mediated Multidrug Resistance Against Doxorubicin in Thyroid Carcinoma FTC-133 Cells.

Authors:  Marie-Pierre Courageot; Laurent Duca; Laurent Martiny; Emmanuelle Devarenne-Charpentier; Hamid Morjani; Hassan El Btaouri
Journal:  Front Oncol       Date:  2020-12-07       Impact factor: 6.244

10.  Effects of taxol resistance gene 1 expression on the chemosensitivity of SGC-7901 cells to oxaliplatin.

Authors:  Liancheng Liu; Zhigang Bai; Xuemei Ma; Tingting Wang; Yao Yang; Zhongtao Zhang
Journal:  Exp Ther Med       Date:  2016-01-13       Impact factor: 2.447
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.